Skip to main content

Adhera Therapeutics, Inc. (ATRX)

OTCMKTS: ATRX · Delayed Price · USD
0.1800 0.0400 (28.57%)
Sep 17, 2021 3:59 PM EDT - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Net Income
-3.77-11.98-16.76-6.22-0.84-1.11-6.48-1.57-9.55-29.42
Depreciation & Amortization
00.080.330.450.050000.561.25
Share-Based Compensation
0.010.771.450.42000.280.140.990.93
Other Operating Activities
3.172.395.374.080.270.371.421.723.6111.13
Operating Cash Flow
-0.59-8.74-9.61-1.26-0.52-0.74-4.780.29-4.39-16.12
Capital Expenditures
00-0.0700000.030.43-0
Acquisitions
00000.0100000
Other Investing Activities
000-0.380000.380.630.01
Investing Cash Flow
00-0.07-0.380.01000.411.060
Share Issuance / Repurchase
00-0.250.42010.0201.1216.02
Debt Issued / Paid
0.655.68-0.141.270.360-0.2501.440
Other Financing Activities
-0.11-0.8113.89-0.05005.92-00.010
Financing Cash Flow
0.544.8713.51.640.3615.69-02.5716.02
Net Cash Flow
-0.05-3.873.810-0.160.260.920.69-0.76-0.09
Free Cash Flow
-0.59-8.74-9.69-1.26-0.52-0.74-4.780.32-3.96-16.12
Free Cash Flow Margin
--3467.46%-12743.42%----955.80%14.89%-93.91%-720.93%
Free Cash Flow Per Share
-0.05-0.81-0.89-0.13-0.01-0.25-1.940.19-2.95-25.47
Showing 10 of 26 years
16 more years are available
Start Free Trial